類天疱瘡重症度スコア(BPDAI) 17+
Manage the BPDAI scores
Takeda Pharmaceuticals International AG
Designed for iPad
-
- Free
Screenshots
Description
・Outline
The purpose of this application is to allow the Bullous Pemphigoid Disease Area Index (BPDAI)*1, a severity assessment technique for pemphigoid, to be utilized in clinical sites and provide a wide variety of programs to manage the scores and display graphs of each patient. In addition, the anti-BP 180 antibody and anti-BP 230 antibody CLEIA index/ELISA index, and skin damage and itching (pruritus) scores (international criteria) can be managed simultaneously.
*1Advocated by the International Pemphigoid Committee.
・Features
* As a criterion guide for the numbers and sizes of erosions, bullae, urticarial lesions, and erythemas in each region is displayed, it is possible to enter data on the spot while examining the patient.
* A score chart (table and graph) for each patient can be displayed on the screen by a simple operation, and the chart can be used to explain the disease condition to the patient.
* The application includes a mail transmission function and a printout function (printers with AirPrint function) for transmitting (PDF file) or printing the scores entered and the score chart for each patient, so that the data can be included in the medical record.
* With regard to external use of management data, the data can be re-used in Excel by transmitting the data as an e-mail attachment (CSV format*2).*3
* With the management data import function, the management data entered in other places can be imported and re-used.*3
* The HELP function can be accessed from the screen.
*2The character code for CSV files is "S-JIS" in both Japanese and English.
*3The items in a CSV file created from management data do not include the patient ID information.
What’s New
Version 1.0.4
Added support for iOS16.x
App Privacy
The developer, Takeda Pharmaceuticals International AG, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Collected
The developer does not collect any data from this app.
Privacy practices may vary based on, for example, the features you use or your age. Learn More
Information
- Provider
- Takeda Pharmaceuticals International AG
- Size
- 42.2 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 12.0 or later.
- iPad
- Requires iPadOS 12.0 or later.
- iPod touch
- Requires iOS 12.0 or later.
- Mac
- Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English
- Age Rating
- 17+ Frequent/Intense Medical/Treatment Information
- Copyright
- © 2023 NIHON PHARMACEUTICAL Co., Ltd.
- Price
- Free